PHARM - Diabetics (Non-Insulin)
33 Questions
9 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the range for prediabetes for A1C? (__ to ___%)

5.7 to 6.4%

What is the A1C that meets the criteria for Diabetes?

6.5%

You should recommend to your diabetic patient to exercise for 150 minutes/week with no more than ____ consecutive days without physical activity

  • 2 (correct)
  • 3
  • 4
  • 5
  • What is the A1C goal for most patients?

    <p>7%</p> Signup and view all the answers

    What is the fast blood glucose goal for diabetic patients?

    <p>80-130</p> Signup and view all the answers

    What is the 2-hour post-prandial blood glucose goal for diabetic patients?

    <p>&lt;180</p> Signup and view all the answers

    Your patient has been taking a medication to help lower their A1C for the past few weeks. Today, the patient's A1C is >1.5% of their goal A1C. What should be considered for this patient?

    <p>Adding/initiating two agents simultaneously</p> Signup and view all the answers

    What Diabetic medication should your T2DM patient be started on based on their comorbidities?

    <p>ASCVD = GLP-RA or SGLT2i Above the age of 55 with two risk factors (obesity, hypertension, smoking, dyslipidemia, albuminuria) = GLP-RA or SGLT2i Heart Failure = SGLT2i ONLY CKD = SGLT2i preferred</p> Signup and view all the answers

    What is the first line diabetic medication for lower A1C by decreasing the hepatic production and intestinal absorption of glucose?

    <p>Metformin</p> Signup and view all the answers

    What patient should NOT take Metformin?

    <p>A patient with unstable heart failure</p> Signup and view all the answers

    What medication needs to be stopped before or at the time of iodinated contrast imaging procedure (based on eGFR)?

    <p>Metformin</p> Signup and view all the answers

    What is the target daily (max) dose of metformin?

    <p>2000 mg</p> Signup and view all the answers

    What patient education can you offer your patient that is starting on Metformin?

    <p>Take on a full stomach to prevent GI AE</p> Signup and view all the answers

    The most common AE for metformin is diarrhea.

    <p>True</p> Signup and view all the answers

    If your patient is maxed of the dose of metformin, but still not at goal, you should add additional agents based on patient specific factors such as cardiorenal risks, weight loss promotion, and cost.

    <p>True</p> Signup and view all the answers

    What medication works in the proximal convoluted tubule by decreasing the reabsorption of filtered glucose (thus increasing excreted glucose in the urine)?

    <p>SGLT-2 inhibitors</p> Signup and view all the answers

    A patient has been taking their medication for diabetes. They present c/o genital itchiness and burning. They are diagnosed with a genital yeast infection and UTI. What medication are they likely taking?

    <p>SGLT-2 inhibitors</p> Signup and view all the answers

    There are specific drug warnings for the SGLT-2 inhibitors (FLOZINS). Match the drug with their specific caution/warning.

    <p>Fracture risk; ↓ bone mineral density = canagliflozin ONLY Increase risk of bladder cancer = dapagliflozin Acute kidney injury = canagliflozin, dapagliflozin Does not have a specific drug warning = Empagliflozin</p> Signup and view all the answers

    A disadvantage to the use of SGLT2i (flozins) is the possibility of Fournier’s gangrene due to recurrent genital mycotic infections.

    <p>True</p> Signup and view all the answers

    What diabetic medication is an agonist to incretins and stimulates insulin release while simultaneously inhibiting glucagon release to lower blood glucose levels?

    <p>GLP-1 RAs</p> Signup and view all the answers

    A patient is wanting to start a medication in addition to their metformin to help lower their A1C, weight, and cardiovascular risks. They report a history of medullary thyroid cancer in their family. What class of medications can this patient NOT take?

    <p>GLP-1 RAs</p> Signup and view all the answers

    What medication can help with lowering blood pressure?

    <p>SGLT-2 inhibitors</p> Signup and view all the answers

    You and your classmates are discussing black box warnings. You know there is a BBW for thyroid C-cell tumors, but are unsure which medication it is for. Which medication does this BBW go with?

    <p>GLP-1 RAs</p> Signup and view all the answers

    What are adverse effects that are seen with GLP-1 RA (-tides)?

    <p>Nausea, Vomiting, Pancreatitis, Gallbladder disease, Diarrhea</p> Signup and view all the answers

    What monitoring is recommended for GLP-1 RA (-tides)?

    <p>Retinopathy</p> Signup and view all the answers

    Mounjaro, GIP-GLP-1/RA COMBO, has additional actions of suppression of glucagon secretion during hyperglycemia and increasing fatty acid and glucose uptake by adipose cells. There is increased weight loss and 1-2% A1C lowering with this medication, but what patient should not use this?

    <p>Hx gastroparesis</p> Signup and view all the answers

    When taking mounjaro, the patient will need backup contraception for 4 weeks after each dose increase if they use oral contraceptive methods.

    <p>True</p> Signup and view all the answers

    What medication works by inhibiting the break down of incretins and therefore indirectly increasing insulin secretion and decreasing glucagon secretion?

    <p>DPP-4 Inhibitors</p> Signup and view all the answers

    You are telling your patient that the medication that they are starting can cause Nasopharyngitis, URI and reversible Arthralgias, otherwise, it is very well tolerated with very low risk of hypoglycemic events. What medication is being described?

    <p>DPP-4 Inhibitors</p> Signup and view all the answers

    DPP-4 Inhibitors can be used in patients with renal insufficiency, but should be dosed lower.

    <p>True</p> Signup and view all the answers

    What PPAR-gamma agonist is less commonly used for A1C lowering due to AE of edema, weight gain, and new onset or worsening of heart failure?

    <p>TZDs</p> Signup and view all the answers

    What drug stimulates pancreatic beta cell insulin secretion to help in the lowering of A1C, but is less commonly used today due to AE of hypoglycemia and weight gain?

    <p>Sulfonylureas</p> Signup and view all the answers

    What medication can be used for post-prandial control and is best taken with first bite of the meal in order to slow carbohydrate absorption?

    <p>a-Glucosidase Inhibitors</p> Signup and view all the answers

    Study Notes

    Diabetes Management

    • The range for prediabetes A1C is not specified, but A1C ≥ 6.5% meets the criteria for Diabetes.
    • The A1C goal for most patients is not specified.

    Exercise and Diabetes

    • Diabetic patients should exercise for 150 minutes/week with no more than 2 consecutive days without physical activity.

    Medication and Diabetes

    • If a patient's A1C is > 1.5% of their goal A1C, consideration should be given to adjusting their medication.
    • Metformin is the first-line diabetic medication to lower A1C by decreasing hepatic production and intestinal absorption of glucose.
    • Patients with severe kidney disease, congestive heart failure, or acute liver disease should not take Metformin.
    • Metformin should be stopped before or at the time of iodinated contrast imaging procedure based on eGFR.
    • The target daily (max) dose of metformin is 2,000 mg.
    • Patient education for Metformin includes staying hydrated, taking with food, and monitoring for diarrhea.
    • If a patient is maxed out on the dose of metformin but still not at goal, additional agents should be added based on patient-specific factors.

    SGLT-2 Inhibitors (FLOZINS)

    • SGLT-2 inhibitors work in the proximal convoluted tubule by decreasing the reabsorption of filtered glucose.
    • A disadvantage to the use of SGLT2i is the possibility of Fournier’s gangrene due to recurrent genital mycotic infections.

    GLP-1 Receptor Agonists

    • GLP-1 receptor agonists stimulate insulin release while simultaneously inhibiting glucagon release to lower blood glucose levels.
    • Adverse effects of GLP-1 RA include pancreatitis and thyroid C-cell tumors.
    • Mounjaro, a GLP-1 RA, has additional actions of suppressing glucagon secretion during hyperglycemia and increasing fatty acid and glucose uptake by adipose cells.
    • Patients with a history of medullary thyroid cancer in their family cannot take GLP-1 RA.

    DPP-4 Inhibitors

    • DPP-4 inhibitors work by inhibiting the breakdown of incretins and therefore indirectly increasing insulin secretion and decreasing glucagon secretion.
    • DPP-4 inhibitors can be used in patients with renal insufficiency, but should be dosed lower.

    Other Medications

    • Sulfonylureas stimulate pancreatic beta-cell insulin secretion to help in the lowering of A1C.
    • Pioglitazone is a PPAR-gamma agonist that is less commonly used for A1C lowering due to AE of edema, weight gain, and new onset or worsening of heart failure.
    • Acarbose can be used for post-prandial control and is best taken with the first bite of the meal to slow carbohydrate absorption.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on the range for prediabetes in terms of A1C levels. Determine the correct percentage range for diagnosing prediabetes based on A1C tests.

    More Like This

    Hemoglobin A1c Control Quiz
    10 questions
    Diabetes and Hemoglobin A1c Quiz
    40 questions
    Use Quizgecko on...
    Browser
    Browser